TY - JOUR
T1 - Impact of chronic kidney disease stages on atherosclerotic plaque components on optical coherence tomography in patients with coronary artery disease
AU - Sugiyama, Tomoyo
AU - Kimura, Shigeki
AU - Ohtani, Hirofumi
AU - Yamakami, Yosuke
AU - Kojima, Keisuke
AU - Sagawa, Yuichiro
AU - Hishikari, Keiichi
AU - Hikita, Hiroyuki
AU - Ashikaga, Takashi
AU - Takahashi, Atsushi
AU - Isobe, Mitsuaki
N1 - Publisher Copyright:
© 2016, Japanese Association of Cardiovascular Intervention and Therapeutics.
PY - 2017/7/1
Y1 - 2017/7/1
N2 - The progression of coronary atherosclerosis has been influenced by the presence of chronic kidney disease (CKD). This study investigated the impact of CKD stages on coronary plaque components observed on optical coherence tomography (OCT). We investigated 296 native coronary lesions with stable angina pectoris treated with stent implantation. All lesions were divided into the three groups according to the values of estimated glomerular filtration rate (eGFR, mL min−1 1.73 m−2): the non-CKD group (eGFR ≥60, n = 142), CKD group (15 ≤ eGFR < 60, n = 126), and end-stage kidney disease (ESKD) group (eGFR <15 and/or hemodialysis, n = 28). Among the groups, plaque morphologies at the narrowest culprit sites on OCT were evaluated. The CKD group had a larger lipid arc [207.5 (88.3–264.5) vs. 159.3 (73.3–227.7) degrees, P = 0.037] and longer lipid length [2.4 (0.0–5.7) vs. 0.0 (0.0–4.7) mm, P = 0.017] than the non-CKD group. The ESKD group had a thinner fibrous cap [120 (70–258) vs. 170 (100–270) μm, P = 0.044], higher prevalence of plaque rupture (28.6 vs. 12.3 %, P = 0.038), and larger calcification arc [124.8 (0.0–194.3) vs. 0.0 (0.0–125.4) degrees, P = 0.025] than the non-ESKD group (CKD + non-CKD groups). The presence of CKD was related to the growth of lipidic plaques. Furthermore, the advancement in the CKD stage to ESKD affected the occurrence of plaque rupture or progression of calcification.
AB - The progression of coronary atherosclerosis has been influenced by the presence of chronic kidney disease (CKD). This study investigated the impact of CKD stages on coronary plaque components observed on optical coherence tomography (OCT). We investigated 296 native coronary lesions with stable angina pectoris treated with stent implantation. All lesions were divided into the three groups according to the values of estimated glomerular filtration rate (eGFR, mL min−1 1.73 m−2): the non-CKD group (eGFR ≥60, n = 142), CKD group (15 ≤ eGFR < 60, n = 126), and end-stage kidney disease (ESKD) group (eGFR <15 and/or hemodialysis, n = 28). Among the groups, plaque morphologies at the narrowest culprit sites on OCT were evaluated. The CKD group had a larger lipid arc [207.5 (88.3–264.5) vs. 159.3 (73.3–227.7) degrees, P = 0.037] and longer lipid length [2.4 (0.0–5.7) vs. 0.0 (0.0–4.7) mm, P = 0.017] than the non-CKD group. The ESKD group had a thinner fibrous cap [120 (70–258) vs. 170 (100–270) μm, P = 0.044], higher prevalence of plaque rupture (28.6 vs. 12.3 %, P = 0.038), and larger calcification arc [124.8 (0.0–194.3) vs. 0.0 (0.0–125.4) degrees, P = 0.025] than the non-ESKD group (CKD + non-CKD groups). The presence of CKD was related to the growth of lipidic plaques. Furthermore, the advancement in the CKD stage to ESKD affected the occurrence of plaque rupture or progression of calcification.
KW - Atherosclerosis
KW - Chronic kidney disease
KW - Coronary disease
KW - Optical coherence tomography
UR - http://www.scopus.com/inward/record.url?scp=85021372535&partnerID=8YFLogxK
U2 - 10.1007/s12928-016-0408-y
DO - 10.1007/s12928-016-0408-y
M3 - Article
C2 - 27339299
AN - SCOPUS:85021372535
SN - 1868-4300
VL - 32
SP - 216
EP - 224
JO - Cardiovascular Intervention and Therapeutics
JF - Cardiovascular Intervention and Therapeutics
IS - 3
ER -